Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski, Igor Bondarenko, Nina A. Karaseva, Anatoly M. Makhson, Igor Vynnychenko, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh,
Interview with partners
Oncology. Huge progress is here. Thoughts of ASCO President 2009-2010. Prof.D.Blayney.
Clinical trials are by all means are essential parts of modern scientific and medical development as well as an important